- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Research Feature
A cell-based look at how the body responds to immune threats may one day help researchers find better treatments for this major U.S. killer For more than a decade, researchers have known that a core component of human immune function – called complement – can influence how the body responds to immune threats. Now researchers from the NIH and around...
Showing 10 out of 344 results
|
Media Advisory
WHAT: A three-part Science of Sleep Series will launch Tuesday afternoons in August through Facebook Live. Researchers will discuss how children and adults can put the latest sleep science into practice to support optimal health outcomes throughout the lifespan. Other topics to be discussed include emerging research and public health opportunities...
|
News Release
A large clinical trial conducted worldwide shows that treating moderately ill hospitalized COVID-19 patients with a full-dose blood thinner reduced their need for organ support, such as mechanical ventilation, and improved their chances of leaving the hospital. However, the use of this treatment strategy for critically ill COVID-19 patients...
|
News Release
Findings underscore need for early treatment to prevent future cardiovascular disease Children with obstructive sleep apnea are nearly three times more likely to develop high blood pressure when they become teenagers than children who never experience sleep apnea, according to a new study funded by the National Heart, Lung, and Blood Institute...
|
News Release
A new study by researchers at the National Institutes of Health and their colleagues has found that SARS-CoV-2, the virus that causes COVID-19, does not appear to pose a threat to the safety of the nation’s blood supply. The analysis, published in Transfusion, supports current donor screening guidelines, including those used by the U.S. Food and...
|
Statement
On World Asthma Day, the National Institutes of Health reaffirms its commitment to research to improve the lives of people with asthma. More than 25 million people in the United States have asthma, including 5.1 million children, according to the Centers for Disease Control and Prevention. This chronic lung disease can reduce quality of life...
|
News Release
Los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) han autorizado $29 millones de dólares en subvenciones adicionales para la Coalición “Alianza de Participación Comunitaria (CEAL, por sus siglas en inglés) de NIH contra las disparidades del COVID-19”. Esta financiación , parte del Plan de Rescate Estadounidense, esta dirigida a...
|
News Release
To bolster research to help communities disproportionately affected by COVID-19, the National Institutes of Health is funding $29 million in additional grants for the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities. This funding was supported by the American Rescue Plan. The awards will provide $15 million to 11 teams already...
|
News Release
A clinical trial shows that cell-based therapy can be safe and feasible for patients with chronic heart failure—patients who currently have limited treatment options. The researchers also reported lower rates of death and hospitalization as well as improvements in quality of life for some. Presented November 13, 2020 at the American Heart...
|
News Release
African Americans who smoke appear to have more than twice the risk of developing coronary heart disease compared to those who do not smoke, a new study has found. The findings—the first up-close look at the relationship between smoking and coronary heart disease in this population—also examined the risk for plaque buildup in the arteries of...
|
Statement
The National Institutes of Health (NIH) has launched the last of three Phase 3 clinical trials to evaluate the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults diagnosed with COVID-19. The first patient in the trial was enrolled on February 15. Part of the Accelerating COVID-19 Therapeutic Interventions...